FDA Warns Drug Manufacturer Strides about Document Shredding
The Food and Drug Administration sent Strides Pharma Science a warning letter regarding violations found during an inspection in January and February of this year.
The agency’s letter, dated July 1, outlined problems in the Indian generic drug manufacturer’s quality unit, including "evidence of uncontrolled shredding of documents," says a news report.